Metabolism of benzo[a]pyrene-3,6-quinone by isolated hepatocytes  by Capdevila, Jorge & Orrenius, Sten
Volume 119, number 1 FEBS LETTERS September 1980 
METABOLISM OF BENZO[ a] PYRENE-3,6-QUINONE BY ISOLATED HEPATOCYTES 
Jorge CAPDEVILA+ and Sten ORRENIUS 
Department of Forensic Medicine, Karolinska Institutet, Box 60 400, S-l 04 01 Stockholm, Sweden and +Department of 
Biochemistry, University of Texas Health Science Center at Dallas, Dallas, TX 75235, USA 
Received 26 July 1980 
1. Introduction 
Quinones are almost invariably found as products 
of the oxidative metabolism of benzo [alpyrene 
supported by rat liver microsomes [ 1,2] or isolated 
hepatocytes [3,4]. Quinones are redox-active com- 
pounds which can enzymatically accept electrons 
from NADPH to form hydroquinone derivatives 
[S-7], or, when, reduced, can donate electrons to 
molecular oxygen to generate reactive species of 
oxygen [5]. During this redox cycle they compete for 
oxygen and reducing equivalents and may thus affect 
the rate of overall metabolism of B[a]P [S]. 
The disposition of B [a] P quinones by the cell 
seems to require that they are first reduced and then 
conjugated prior to being eliminated as water-soluble 
products [.5-71. Hence the addition of uridine-S’- 
diphosphate glucuronic acid to incubation mixtures 
containing rat liver microsomes, B[a]P and NADPH 
has a stimulatory effect on the rate of B[a]P metab- 
olism [&lo] and also results in the conversion of 
most of the B[a]P quinones to water-soluble conju- 
gates [7-l 11. The microsomal conversion of B[a]P 
quinones to glucuronides is NADPH-dependent and 
has been reported to be dicoumarol-sensitive suggest- 
ing a role for DT-diaphorase in this process [7]. On 
the other hand, the microsomal cytochrome P450 
reductase is a very active B[a]P quinone reductase 
which catalyzes the formation of hydroquinones at 
substantially higher rates than DT-diaphorase [6]; this 
enzyme is NADPH-dependent and is not inhibited by 
dicoumarol [6]. 
Abbreviations: B[a]P, benzo(a)pyrene; UDPGA, urrdine-S’- 
diphosphate glucuronic acid; Hepes, N-2-hydroxyethylpi- 
perazine-N’-2-ethanesulfonic acid;GSH, glutathione, reduced 
form 
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Here we have used isolated hepatocytes and the 
liver-microsomal fraction obtained from phenobarbital. 
treated rats to study the reduction of B [a]P-3,6- 
quinone, the sensitivity of this reaction to dicoumarol, 
and the role of glucuronide formation in quinone 
disposition by the cell. 
2. Materials and methods 
B [a]P-3,6-quinone was obtained from the NC1 
Carcinogenesis Research Program, Bethesda, MD. It 
was dissolved in dimethylsulfoxide and its concentra- 
tion determined by spectrophotometry. Other chem- 
icals used were obtained at the highest purity avail- 
able commercially. 
Microsomal fraction and hepatocytes were isolated 
from the livers of phenobarbital-treated male Sprague- 
Dawley rats (200-250 g) as in [4,12]. 
NADPH-dependent, microsomal reduction of 
B [a]P-3,6-quinone was assayed as in [6], except that 
Krebs-Henseleit buffer (pH 7.4) containing 25 mM 
Hepes was used instead of Tris-HCl buffer. The 
metabolism of B [a]P-3,6-quinone by isolated hepato- 
cytes was studied by dividing a cell suspension 
(l-3 X lo6 cells/ml) between the sample and refer- 
ence cuvettes of an Aminco DW-2spectrophotom- 
eter. After recording a baseline of equal absorbance, 
the reaction was initiated by adding the B [a]P-3,6- 
quinone to the sample cuvette. Repetitive scanning 
was performed between 380 and 680 nm with contin- 
uous mixing of both sample and reference cuvettes to 
avoid cell sedimentation and anaerobiosis. 
The rate of quinone reduction catalyzed by iso- 
lated hepatocytes was determined spectrophotomet- 
rically in the dual wavelength mode, monitoring the 
time-dependent change in absorbance for the wave- 
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length pair 458-485 nm. A 20 ml ceil suspension in 
Krebs-Henseleit buffer (pH 7.4) containing 25 mM 
Hepes, and 3 mM salicylamide, with or without the 
addition of dicoumarol (10 ,uM final cont.), was kept 
in a pyrex beaker (3.7 cm lightpath) placed in the 
beampath of the spectrophotometer [ 131. The sus- 
pension was mixed with the aid of a magnetic stirrer. 
After balancing the absorbance difference between 
458 and 485 nm, the reaction was started by adding 
the B[a]P-3,Cquinone. 
All the results reported here were obtained at 
25°C. 
3. Results and discussion 
The time-dependent changes in Iight absorbance 
upon addition of B [a] P-3,6-quinone to a suspension 
of isolated hepatocytes are shown in fig. 1. The rapid 
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reduction of the quinone to its hydroquinone form is 
indicated by the loss of absorbance at -480 nm and 
the appearance of a transient shoulder at -448 mn 
(frg.1, line 2: [6]). As the reaction proceeded, there 
was a continuous decrease in quinone concentration 
(480 nm) and, at the same time. the absorbance band 
at 448 nm progressively shifted towards lower wave- 
lengths (fig. 1, lines 3-5). The system reached a 
steady-state at -I 1 min after addition of B[a]P-3,6- 
quinone, with the resulting spectrum showing maxima 
at 390 and 437 nm (fig. 1, line 6). This was not 
changed even after 40 min incubation and was unal- 
tered when Na&04 was added to the contents of 
both sample and reference cuvettes. The latter indi- 
cates that under these conditions essentially all of the 
added quinone had been metabolized to originate the 
spectral intermediate above. 
As described [6], the NADPH-dependent reduc- 
tion of B~a]P-3,6-quinone catalyzed by liver micro- 
somes obtained from phenobarbital-treated rats 
resulted in a loss of absorbance at -480 nm and the 
concomitant appearance of a typical hydroquinone 
spectrum with absorption maxima at 401 and 448 
nm. Under conditions of limiting NADPH, these 
spectral changes were reversed upon depletion of 
reducing equivalents and the spectrum of the fully 
oxidized quinone was recovered. The addition of 
GSH (5 mM final cont.) to the incubation had no 
apparent effect on the shape of the spectral changes 
described. On the other hand, and as shown in fig.‘, 
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Fig.]. Spectral analysis of the metabohsm of B[a] P-3,6qumone by isotated hepatocytes. A celf suspension f 1.8 X I O6 cells/ml) 
was placed in the sample and reference cuvettes of the spectrophotometer and a baseline of equal absorbance was recorded (line 
1). The reaction was then initiated by the addition of B(a]P-3,6quinone (7.3 PM) to the sample cuvette, and immediately there- 
after the spectrum shown by line 2 was obtained. Scanning of the reaction mixture was then repeated at 3,6,9 and 12 min (lines 
3,4,5 and 6, respectively). 
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Fig.2. Spectral analysis of the microsomai metabolism of B~a]P-3,4-quinone in the presence of UDPGA. A suspenston of liver 
microsomes (0.8 mg protein/ml) containing UDPGA (5 mM final cont.) and an NADPH-regenerating system (except NADPH), 
was placed in the sample and reference cuvettcs of the spectrophotometer and the baseline (line 1) was recorded. After addition 
of B[a]P-3,6quinone (7.3 PM) to the sample cuvette the spectrum shown by line 2 was recorded. The reaction was then Initiated 
by the addition of NADPH (0.4 tnM) to the contents of both sample and reference cuvettes. Spectra shown by lines 3,4 and 5 
were recorded at 4.20 and 45 min after initiation of the reaction, respectively. 
when the microsome-catalyzed reaction was assayed 
in the presence of UDPGA (5 mM final cont.) a spec- 
tral intermediate similar to that obtained with the 
isolated hepatocytes was formed. For the experiment 
illustrated in fig.2, we divided a microsomal suspen- 
sion containing an NADPH-regenerating system and 
5 mM UDPGA between the sample and reference 
cuvettes of the spectrophotometer. After establishing 
a baseline of equal absorbance (fig.2, line I), the 
3[aJP-3,6-quinone was added to the contents of the 
sample cuvette and the spectrum shown by line 2 
(fig.2) was recorded. This contains superimposed to 
the typical quinone band, the contribution of a type 
I complex formed between the.quinone and ferric 
cytochrome P450 [6]. Upon addition of NADPH to 
the sample and reference cuvettes, the rapid reduc- 
tion of the quinone resulted in a loss of absorbance 
at -480 nm and the appearance of the bands at 401 
and 448 nm. An apparent steady-state of reduction 
was obtained after 4 min incubation (fig.2, line 3). 
However, as the reaction proceeded with time, there 
was a gradual shift of the absorbance maxima at 401 
and 448 nm towards lower wavelengths; this is clearly 
shown by the absorbance of the incubation mixture 
registered 20 min after initiation of the reaction with 
NADPH (fig.2, line 4). Finally, after 45 min incuba- 
tion under continuous mixing, the reaction reached a 
new steady-state which is illustrated by line 5 (fig.2). 
This spectral species remained unchanged even after 
60 min and was not affected when NazSz04 was 
added to the contents of both sample and reference 
cuvettes. 
The products of the hepatocyte-supported metab- 
olism of B[a]P-3,&quinone and of that catalyzed by 
the microsomal fraction fortified with NADPH and 
UDPGA are spectrally almost identical (compare lines 
6 and 5 of fig.1 and 2), the major difference being 
that formation of the ultimate spectral species seems 
to occur more rapidly with hepatocytes than with the 
microsomal fraction. Thus, it appears that hepatocytes 
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do reduce B [a]P-3,6-quinone and that the hydroqui- 
none is subsequently rapidly conjugated with glu- 
curonic acid. This is further substantiated by the 
results shown in fig.3. In this experiment the hepato- 
cytes were preincubated for 2 min with salicylamide 
prior to the addition of the B [a] P-3,6-quinone; sali- 
cylamide is a potent inhibitor of glucuronic acid and 
sulfate conjugation in hepatocytes [4]. As shown in 
fig.3, the addition of B [a] P-3,6-quinone to the cell 
suspension in the presence of salicylamide resulted in 
the rapid conversion of the quinone to its hydroqui- 
none form (fig.3, lines 2,3). At -6 min after initiation 
of the reaction, the system reached a steady-state in 
which -6O-70% of the added quinone was present as 
hydroquinone (fig.3, line 4). This remained constant 
for at least 1.5 min and upon addition of Na2S204 to 
both the sample and reference cuvettes, the spectrum 
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of the fully reduced hydroquinone was obtained (fig.3, 
line 5). 
The results shown so far indicate that in isolated 
hepatocytes the B [a] P-3,6-quinone is rapidly reduced 
to a hydroquinone which is then efficiently conju- 
gated with UDPGA. It must be noted, however, that a 
sulfate conjugate would not be spectrally distinguish- 
able from a glucuronide under our conditions of 
analysis, since the bands obtained at 390 and 437 run 
are mainly due to the aromatic residue of the poly- 
cyclic hydrocarbon and its resonance properties are 
very similar for both types of conjugates. In an 
experiment not shown here, we therefore extracted 
the water-soluble products of a reaction mixture con- 
taining isolated hepatocytes (3 X IO6 cells/ml) and 
B [a]P-3,6-quinone (15 PM), incubated at 25°C for 
50 min, which were then hydrolyzed with /3-glucu- 
ronidase as in [4]. After extraction of the hydrolysate 
with ethylacetate, B[a]P-3,6-quinone was recovered 
in the organic phase suggesting that, indeed, the glu- 
curonic acid conjugate of the hydroquinone is a 
major water-soluble metabolite of B [a]P-3,6-quinone 
in hepatocytes. 
Table 1 compares the rates of B [a]P-3,6-quinone 
reduction with NADPH-fortified microsomal fraction 
and isolated hepatocytes; quinone reduction in iso- 
lated hepatocytes was assayed in the presence of sali- 
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Fig.3. Spectral analysis of the metabolism of B[a]P-3,6quinone by isolated hepatocytes in the presence of salicylamide. A cell 
suspension (1.8 X 1 O6 cells/ml) was preincubated with salicylamide (2 mM final cont.) for 2 min prior to addition to the sample 
and reference cuvettes of the spectrophotometer. A baseline of equal absorbance (line 1) was recorded. After initiation of the 
reaction by adding B[a]P-3,6-quinone (7.3 PM) to the sample cuvette. spectra shown by lines 2,3 and 4 were recorded at 0, 3 and 
6 min after initiation of the reaction. respectively. When a spectral steady-state was achrevcd, Na,S,O, was added to the contents 
of both sample and reference cuvettes and the spectrum shown by line 5 was recorded. 
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Tdble 1 
Rate of reduction of benzo[a]pyrene-3,6quinone catalyzed 
by liver microsomes and isolated hepatocytes 
Experimental 
system 
Control + Dicoumarol 
(10 PM) 
Microsomes 
(nmol min-* mg prot.-I)” 168 165 
Hepatocytes 
(nmol . min-’ lo6 cells-‘)b 14.6 15.3 
a Values given for the microsomal reaction were obtained 
from [6] 
b Values shown correspond to av. 3 determinations per- 
formed in the presence of 2 mM salicylamide. The reaction 
was initiated by addition of B[a]P-3.6quinone to 15 PM 
final cont. 
cylamide (2 mM) as in section 2. The rate of reduc- 
tion catalyzed by the microsomal fraction was found 
to be 3-4-fold higher than that observed with the cell 
preparation ( lo6 hepatocytes correspond to -0.35 
mg microsomal protein). Several factors may have 
contributed to the observed difference in rates of qui- 
none reduction in the two experimental systems 
including possible differences in availability of qui- 
none and NADPH at saturating concentrations at the 
metabolic sites. The presence of dicoumarol(l0 /.LM) 
in the reaction mixture containing either microsomal 
fraction or isolated hepatocytes had no apparent 
effect on the rate of B[a]P-3,6-quinone reduction 
(table I), indicating that DT-diaphorase may in fact 
play a minor role, if any, in the reduction of the 
quinone by hepatocytes as well as by the microsomal 
fraction [6]. 
We have provided evidence that isolated hepato- 
cytes catalyze the reduction of B[a]P-3,6-quinone 
to its hydroquinone form, and that the hydroquinone 
is subsequently conjugated, mainly with glucuronic 
acid, prior to its disposition as a water-soluble prod- 
uct. Moreover, our results suggest hat reduction of 
the quinone in the intact cell is catalyzed primarily 
by cytochrome P450 reductase, and not by DT-dia- 
phorase, in accordance with findings with microsomes 
[6]. Our results reveal a high capacity of the hepato- 
cytes to rapidly conjugate the hydroquinone formed, 
a mechanism which may protect the cell from forma- 
tion of reactive species of oxygen as the result of 
autooxidation of accumulating hydroquinone [S]. 
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